|
CDCA2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.036980E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.586810E-01 |
| Normal-vs-Stage2 |
9.080900E-03 |
| Normal-vs-Stage3 |
9.989800E-02 |
| Normal-vs-Stage4 |
1.693200E-01 |
| Stage1-vs-Stage2 |
7.59120000000113E-05 |
| Stage1-vs-Stage3 |
4.557000E-01 |
| Stage1-vs-Stage4 |
9.083000E-01 |
| Stage2-vs-Stage3 |
8.844100E-03 |
| Stage2-vs-Stage4 |
1.484350E-02 |
| Stage3-vs-Stage4 |
6.698800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.498390E-01 |
| Normal-vs-AfricanAmerican |
2.219800E-02 |
| Normal-vs-Asian |
1.372600E-01 |
| Caucasian-vs-AfricanAmerican |
1.636210E-02 |
| Caucasian-vs-Asian |
7.705600E-01 |
| AfricanAmerican-vs-Asian |
1.044770E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.346170E-01 |
| Normal-vs-Female |
9.776300E-02 |
| Male-vs-Female |
6.799800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.332000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.634500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.242390E-01 |
| Normal-vs-Age(81-100Yrs) |
6.678600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.392000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.511800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.713600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.409620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.596100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.649900E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.164200E-01 |
| Classical-VS-Follicular |
4.40400000000229E-05 |
| Classical-VS-Other |
1.682160E-01 |
| Classical-VS-Normal |
1.725550E-01 |
| Tall-VS-Follicular |
4.450200E-02 |
| Tall-VS-Other |
2.740800E-01 |
| Tall-VS-Normal |
2.933400E-01 |
| Follicular-VS-Other |
5.279800E-01 |
| Follicular-VS-Normal |
1.092070E-02 |
| Other-VS-Normal |
5.589700E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.468400E-02 |
| Normal-vs-N1 |
8.405900E-02 |
| N0-vs-N1 |
7.970800E-01 |
|
|
